FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081631915> ?p ?o ?g. }

• W3081631915 endingPage "141" @default.
• W3081631915 startingPage "129" @default.
• W3081631915 abstract "Abstract As patients with chronic hepatitis C virus (HCV) tend to be older and/or have advanced liver disease in Japan, real‐world data are needed to evaluate safe and effective treatment options. The study aim was to assess safety and effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in a real‐world cohort of Japanese patients with HCV genotype (GT) 1 infection overall and by patient subgroups: elderly, compensated cirrhotic, advanced fibrotic and those with hepatocellular carcinoma (HCC). A large prospective observational study was conducted, enrolling adult patients treated for HCV GT1 infection with LDV/SOF at clinical sites across Japan. Patients were observed for safety outcomes during and 4 weeks after treatment, and for sustained virologic response at 12‐weeks post‐treatment (SVR12). Incidence rates (IRs) of adverse drug reactions (ADRs) and serious ADRs (SADRs) and SVR12 rates were assessed overall and by subgroups. ADR and SADR IRs were low (2.26 and 0.17 per 100 person‐months, respectively) and did not significantly differ in elderly patients or those with presence of compensated cirrhosis, worsening fibrosis or HCC. SVR12 rates were high overall (98.5%) and across subgroups investigated (≥94%), including patients who were elderly (98.2%), treatment‐experienced (97.6%), advanced fibrotic (≥95.8%), had existing NS5A resistance‐associated substitutions reported pre‐treatment (95.0%), compensated cirrhosis (95.7%), HCC (94.0%) and other chronic liver diseases (96.1%). In this large, real‐world observational study of Japanese patients with HCV GT1 infection, LDV/SOF treatment resulted in low incidence of adverse events, with high real‐world effectiveness, even among patients with potentially higher risks of adverse safety outcomes and treatment failure." @default.
• W3081631915 created "2020-09-08" @default.
• W3081631915 creator A5020584668 @default.
• W3081631915 creator A5022433565 @default.
• W3081631915 creator A5027146598 @default.
• W3081631915 creator A5029936292 @default.
• W3081631915 creator A5034938550 @default.
• W3081631915 creator A5052818896 @default.
• W3081631915 creator A5062402842 @default.
• W3081631915 creator A5067141010 @default.
• W3081631915 date "2020-09-16" @default.
• W3081631915 modified "2023-10-17" @default.
• W3081631915 title "Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan" @default.
• W3081631915 cites W1732930179 @default.
• W3081631915 cites W1888976023 @default.
• W3081631915 cites W2066725789 @default.
• W3081631915 cites W2081897332 @default.
• W3081631915 cites W2092646281 @default.
• W3081631915 cites W2100460925 @default.
• W3081631915 cites W2101598010 @default.
• W3081631915 cites W2151554611 @default.
• W3081631915 cites W2155965977 @default.
• W3081631915 cites W2157294800 @default.
• W3081631915 cites W2258263090 @default.
• W3081631915 cites W2363290905 @default.
• W3081631915 cites W2413213127 @default.
• W3081631915 cites W2463921556 @default.
• W3081631915 cites W2470344850 @default.
• W3081631915 cites W2510623134 @default.
• W3081631915 cites W2512251569 @default.
• W3081631915 cites W2515985363 @default.
• W3081631915 cites W2538194643 @default.
• W3081631915 cites W2558567422 @default.
• W3081631915 cites W2564813289 @default.
• W3081631915 cites W2593764560 @default.
• W3081631915 cites W2609928580 @default.
• W3081631915 cites W2749229801 @default.
• W3081631915 cites W2777856481 @default.
• W3081631915 cites W2784193918 @default.
• W3081631915 cites W2795863480 @default.
• W3081631915 cites W2807126090 @default.
• W3081631915 cites W2883097184 @default.
• W3081631915 cites W2897919916 @default.
• W3081631915 cites W2939416704 @default.
• W3081631915 cites W2958929388 @default.
• W3081631915 doi "https://doi.org/10.1111/jvh.13395" @default.
• W3081631915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32869924" @default.
• W3081631915 hasPublicationYear "2020" @default.
• W3081631915 type Work @default.
• W3081631915 sameAs 3081631915 @default.
• W3081631915 citedByCount "4" @default.
• W3081631915 countsByYear W30816319152021 @default.
• W3081631915 countsByYear W30816319152022 @default.
• W3081631915 crossrefType "journal-article" @default.
• W3081631915 hasAuthorship W3081631915A5020584668 @default.
• W3081631915 hasAuthorship W3081631915A5022433565 @default.
• W3081631915 hasAuthorship W3081631915A5027146598 @default.
• W3081631915 hasAuthorship W3081631915A5029936292 @default.
• W3081631915 hasAuthorship W3081631915A5034938550 @default.
• W3081631915 hasAuthorship W3081631915A5052818896 @default.
• W3081631915 hasAuthorship W3081631915A5062402842 @default.
• W3081631915 hasAuthorship W3081631915A5067141010 @default.
• W3081631915 hasConcept C120665830 @default.
• W3081631915 hasConcept C121332964 @default.
• W3081631915 hasConcept C126322002 @default.
• W3081631915 hasConcept C159047783 @default.
• W3081631915 hasConcept C197934379 @default.
• W3081631915 hasConcept C23131810 @default.
• W3081631915 hasConcept C2522874641 @default.
• W3081631915 hasConcept C2775999097 @default.
• W3081631915 hasConcept C2776408679 @default.
• W3081631915 hasConcept C2776455275 @default.
• W3081631915 hasConcept C2777075537 @default.
• W3081631915 hasConcept C2777214474 @default.
• W3081631915 hasConcept C2778019345 @default.
• W3081631915 hasConcept C2778390639 @default.
• W3081631915 hasConcept C2780040827 @default.
• W3081631915 hasConcept C61511704 @default.
• W3081631915 hasConcept C71924100 @default.
• W3081631915 hasConcept C90924648 @default.
• W3081631915 hasConceptScore W3081631915C120665830 @default.
• W3081631915 hasConceptScore W3081631915C121332964 @default.
• W3081631915 hasConceptScore W3081631915C126322002 @default.
• W3081631915 hasConceptScore W3081631915C159047783 @default.
• W3081631915 hasConceptScore W3081631915C197934379 @default.
• W3081631915 hasConceptScore W3081631915C23131810 @default.
• W3081631915 hasConceptScore W3081631915C2522874641 @default.
• W3081631915 hasConceptScore W3081631915C2775999097 @default.
• W3081631915 hasConceptScore W3081631915C2776408679 @default.
• W3081631915 hasConceptScore W3081631915C2776455275 @default.
• W3081631915 hasConceptScore W3081631915C2777075537 @default.
• W3081631915 hasConceptScore W3081631915C2777214474 @default.
• W3081631915 hasConceptScore W3081631915C2778019345 @default.
• W3081631915 hasConceptScore W3081631915C2778390639 @default.
• W3081631915 hasConceptScore W3081631915C2780040827 @default.
• W3081631915 hasConceptScore W3081631915C61511704 @default.
• W3081631915 hasConceptScore W3081631915C71924100 @default.
• W3081631915 hasConceptScore W3081631915C90924648 @default.

• next